These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 15193060)

  • 1. [Diagnostic value of limited research in patients with irritable bowel syndrome].
    Sánchez RC; Navarro Cano G
    Rev Gastroenterol Mex; 2004; 69(1):24-9. PubMed ID: 15193060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Organic colonic lesions in patients with irritable bowel syndrome (IBS).
    Akhtar AJ; Shaheen MA; Zha J
    Med Sci Monit; 2006 Sep; 12(9):CR363-7. PubMed ID: 16940928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the alternating bowel habit subtype in patients with irritable bowel syndrome.
    Tillisch K; Labus JS; Naliboff BD; Bolus R; Shetzline M; Mayer EA; Chang L
    Am J Gastroenterol; 2005 Apr; 100(4):896-904. PubMed ID: 15784038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [An epidemiologic study of irritable bowel syndrome in Beijing - a stratified randomized study by clustering sampling].
    Pan G; Lu S; Ke M; Han S; Guo H; Fang X
    Zhonghua Liu Xing Bing Xue Za Zhi; 2000 Feb; 21(1):26-9. PubMed ID: 11860753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Additional investigations fail to alter the diagnosis of irritable bowel syndrome in subjects fulfilling the Rome criteria.
    Hamm LR; Sorrells SC; Harding JP; Northcutt AR; Heath AT; Kapke GF; Hunt CM; Mangel AW
    Am J Gastroenterol; 1999 May; 94(5):1279-82. PubMed ID: 10235207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value of different diagnostic criteria for the irritable bowel syndrome among men and women.
    Hammer J; Talley NJ
    J Clin Gastroenterol; 2008 Feb; 42(2):160-6. PubMed ID: 18209586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different segmental transit times in patients with irritable bowel syndrome and "normal" colonic transit time: is there a correlation with symptoms?
    Bouchoucha M; Devroede G; Dorval E; Faye A; Arhan P; Arsac M
    Tech Coloproctol; 2006 Dec; 10(4):287-96. PubMed ID: 17115321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of irritable bowel syndrome: a community survey.
    Wilson S; Roberts L; Roalfe A; Bridge P; Singh S
    Br J Gen Pract; 2004 Jul; 54(504):495-502. PubMed ID: 15239910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Frequency of celiac disease and irritable bowel syndrome coexistance and its influence on the disease course].
    Zwolińska-Wcisło M; Galicka-Latała D; Rozpondek P; Rudnicka-Sosin L; Mach T
    Przegl Lek; 2009; 66(3):126-9. PubMed ID: 19689036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [BMW diagnostic criteria for IBS].
    Matsueda K
    Nihon Rinsho; 2006 Aug; 64(8):1431-6. PubMed ID: 16898607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Change over time of bowel habit in irritable bowel syndrome: a prospective, observational, 1-year follow-up study (RITMO study).
    Garrigues V; Mearin F; Badía X; Balboa A; Benavent J; Caballero A; Domínguez E; Díaz-Rubio M; Roset M; Figueras M; Cucala M;
    Aliment Pharmacol Ther; 2007 Feb; 25(3):323-32. PubMed ID: 17217445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-diarrhea chronic intestinal symptoms and irritable bowel syndrome in North American travelers to Mexico.
    Okhuysen PC; Jiang ZD; Carlin L; Forbes C; DuPont HL
    Am J Gastroenterol; 2004 Sep; 99(9):1774-8. PubMed ID: 15330917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinical course of postinfectious irritable bowel syndrome: a five-year follow-up study.
    Jung IS; Kim HS; Park H; Lee SI
    J Clin Gastroenterol; 2009 Jul; 43(6):534-40. PubMed ID: 19262407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Symptomatic efficacy of beidellitic montmorillonite in irritable bowel syndrome: a randomized, controlled trial.
    Ducrotte P; Dapoigny M; Bonaz B; Siproudhis L
    Aliment Pharmacol Ther; 2005 Feb; 21(4):435-44. PubMed ID: 15709995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Manitoba Inflammatory Bowel Disease Cohort Study: prolonged symptoms before diagnosis--how much is irritable bowel syndrome?
    Burgmann T; Clara I; Graff L; Walker J; Lix L; Rawsthorne P; McPhail C; Rogala L; Miller N; Bernstein CN
    Clin Gastroenterol Hepatol; 2006 May; 4(5):614-20. PubMed ID: 16630762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of irritable bowel syndrome according to different diagnostic criteria in a non-selected adult population.
    Hillilä MT; Färkkilä MA
    Aliment Pharmacol Ther; 2004 Aug; 20(3):339-45. PubMed ID: 15274671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for irritable bowel syndrome in Turkish population: role of food allergy.
    Uz E; Türkay C; Aytac S; Bavbek N
    J Clin Gastroenterol; 2007 Apr; 41(4):380-3. PubMed ID: 17413606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Irritable bowel syndrome among patients attending General Outpatients' clinics in Jos, Nigeria.
    Ladep NG; Okeke EN; Samaila AA; Agaba EI; Ugoya SO; Puepet FH; Malu AO
    Eur J Gastroenterol Hepatol; 2007 Sep; 19(9):795-9. PubMed ID: 17700266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of irritable bowel syndrome among undergraduates in Southeast China.
    Dai N; Cong Y; Yuan H
    Dig Liver Dis; 2008 Jun; 40(6):418-24. PubMed ID: 18339591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiologic study of the irritable bowel syndrome in Beijing: stratified randomized study by cluster sampling.
    Pan G; Lu S; Ke M; Han S; Guo H; Fang X
    Chin Med J (Engl); 2000 Jan; 113(1):35-9. PubMed ID: 11775207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.